Literature DB >> 19730986

When pre-test probability can be deceptive.

Micaela La Regina, Maria Cristina Pierantoni, Massimo Ratti, Francesco Orlandini.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 19730986     DOI： 10.1007/s11739-009-0305-9

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  6 in total

1.  Is clinical probability assessment of deep vein thrombosis by a score really standardized?

Authors:  A Bigaroni; A Perrier; H Bounameaux
Journal:  Thromb Haemost       Date:  2000-05       Impact factor: 5.249

2.  UK patients with deep-vein thrombosis can be safely treated as out-patients.

Authors:  D O'Shaughnessy; J Miles; J Wimperis
Journal:  QJM       Date:  2000-10

3.  Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation.

Authors:  D Imberti; W Ageno; F Dentali; M Giorgi Pierfranceschi; E Croci; D Garcia
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

4.  Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins.

Authors:  Sergio Siragusa; Raffaela Anastasio; Camillo Porta; Francesco Falaschi; Stefano Pirrelli; Piernicola Palmieri; Gabriella Gamba; Katerina Granzow; Alessandra Malato; Viviana Minardi; Paola Tatoni; Maria Antonietta Bressan; Guglielmo Mariani
Journal:  Arch Intern Med       Date:  2004 Dec 13-27

5.  Thrombosis in the emergency department: use of a clinical diagnosis model to safely avoid the need for urgent radiological investigation.

Authors:  D R Anderson; P S Wells; I Stiell; B MacLeod; M Simms; L Gray; K S Robinson; J Bormanis; M Mitchell; B Lewandowski; G Flowerdew
Journal:  Arch Intern Med       Date:  1999-03-08

6.  Dalteparin in emergency patients to prevent admission prior to investigation for venous thromboembolism.

Authors:  D L Bauld; M J Kovacs
Journal:  Am J Emerg Med       Date:  1999-01       Impact factor: 2.469
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.